Mayumi Nakagawa

Molecular analysis of the human esterase D gene ESD(*)Q0(yonago) responsible for incompatibility in a Japanese paternity case.

Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women.

Different methods of identifying new antigenic epitopes of human papillomavirus type 16 E6 and E7 proteins.

Safe lead levels: blood transfusion of extremely low birth weight infants.

Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.

Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.

Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.

Patterns of CD8 T-cell epitopes within the human papillomavirus type 16 (HPV 16) E6 protein among young women whose HPV 16 infection has become undetectable.

Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.

HLA class I binding promiscuity of the CD8 T-cell epitopes of human papillomavirus type 16 E6 protein.

Detection of human papillomavirus type 16-specific T lymphocytes by a recombinant vaccinia virus-based enzyme-linked immunospot assay.

A novel CD4 T-cell epitope described from one of the cervical cancer patients vaccinated with HPV 16 or 18 E7-pulsed dendritic cells.

Memory T cells specific for novel human papillomavirus type 16 (HPV16) E6 epitopes in women whose HPV16 infection has become undetectable.

[Structural homology between streptolysin O (SLO) produced by streptococcus pyogenes and SLO-like protein produced by non-pathogenic streptococci and cross-reactivity of antibody against SLO-like protein to SLO].

Molecular basis of complement factor I (CFI) polymorphism: one of two polymorphic suballeles responsible for CFI A is Japanese-specific.

Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection.

A homozygous protein C deficiency (Lys 192 del) who developed venous thrombosis for the first time at adulthood.

A favorable clinical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 e6 antigens in women being studied for abnormal pap smear results.

A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal.

Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.

Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.